Nancy J. Hutson, Director at BIOCRYST PHARMACEUTICALS INC (BCRX), bought 10,000 shares at $10.27 ($103K) on 2015-02-20, disclosed to the SEC on 2015-02-23.
Open-market purchase of $103k BCRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| CLSD | BUY | 2023-10-04 | $9K | — | Filing → |
| BCRX | SELL | 2023-06-15 | $207K | — | Filing → |
| CLSD | BUY | 2022-11-21 | $40K | — | Filing → |